Dataset Information

Robust Bayesian Analysis of Early-Stage Parkinson's Disease Progression Using DaTscan Images.

ABSTRACT: This paper proposes a mixture of linear dynamical systems model for quantifying the heterogeneous progress of Parkinson's disease from DaTscan Images. The model is fitted to longitudinal DaTscans from the Parkinson's Progression Marker Initiative. Fitting is accomplished using robust Bayesian inference with collapsed Gibbs sampling. Bayesian inference reveals three image-based progression subtypes which differ in progression speeds as well as progression trajectories. The model reveals characteristic spatial progression patterns in the brain, each pattern associated with a time constant. These patterns can serve as disease progression markers. The subtypes also have different progression rates of clinical symptoms measured by MDS-UPDRS Part III scores.

SUBMITTER: Zhou Y

PROVIDER: S-EPMC7899013 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Robust Bayesian Analysis of Early-Stage Parkinson's Disease Progression Using DaTscan Images.

Zhou Yuan Y Tinaz Sule S Tagare Hemant D HD

IEEE transactions on medical imaging 20210202 2

This paper proposes a mixture of linear dynamical systems model for quantifying the heterogeneous progress of Parkinson's disease from DaTscan Images. The model is fitted to longitudinal DaTscans from the Parkinson's Progression Marker Initiative. Fitting is accomplished using robust Bayesian inference with collapsed Gibbs sampling. Bayesian inference reveals three image-based progression subtypes which differ in progression speeds as well as progression trajectories. The model reveals character ...[more]

PMID: 33055025

Similar Datasets

Project description:Background: The substantial heterogeneity of clinical symptoms and lack of reliable progression markers in Parkinson's disease (PD) present a major challenge in predicting accurate progression and prognoses. Increasing evidence indicates that each component of the neurovascular unit (NVU) and blood-brain barrier (BBB) disruption may take part in many neurodegenerative diseases. Since some portions of CSF are eliminated along the neurovascular unit and across the BBB, disturbing the pathways may result in changes of these substances. Methods: Four hundred seventy-four participants from the Parkinson's Progression Markers Initiative (PPMI) study (NCT01141023) were included in the study. Thirty-six initial features, including general information, brief clinical characteristics and the current year's classical scale scores, were used to build five regression models to predict PD motor progression represented by the coming year's Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III score after redundancy removal and recursive feature elimination (RFE)-based feature selection. Then, a threshold range was added to the predicted value for more convenient model application. Finally, we evaluated the CSF and blood biomarkers' influence on the disease progression model. Results: Eight hundred forty-nine cases were included in the study. The adjusted R 2 values of three different categories of regression model, linear, Bayesian and ensemble, all reached 0.75. Models of the same category shared similar feature combinations. The common features selected among the categories were the MDS-UPDRS Part III score, Montreal Cognitive Assessment (MOCA) and Rapid Eye Movement Sleep Behavior Disorder Questionnaire (RBDSQ) score. It can be seen more intuitively that the model can achieve certain prediction effect through threshold range. Biomarkers had no significant impact on the progression model within the data in the study. Conclusions: By using machine learning and routinely gathered assessments from the current year, we developed multiple dynamic models to predict the following year's motor progression in the early stage of PD. These methods will allow clinicians to tailor medical management to the individual and identify at-risk patients for future clinical trials examining disease-modifying therapies.

Dataset Information

Robust Bayesian Analysis of Early-Stage Parkinson's Disease Progression Using DaTscan Images.

Publications

Robust Bayesian Analysis of Early-Stage Parkinson's Disease Progression Using DaTscan Images.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets